For: | Sagnelli E, Potenza N, Onorato L, Sagnelli C, Coppola N, Russo A. Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma. World J Hepatol 2018; 10(9): 558-570 [PMID: 30310534 DOI: 10.4254/wjh.v10.i9.558] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v10/i9/558.htm |
Number | Citing Articles |
1 |
Armando Di Palo, Chiara Siniscalchi, Nicola Mosca, Aniello Russo, Nicoletta Potenza. A Novel ceRNA Regulatory Network Involving the Long Non-Coding Antisense RNA SPACA6P-AS, miR-125a and its mRNA Targets in Hepatocarcinoma Cells. International Journal of Molecular Sciences 2020; 21(14): 5068 doi: 10.3390/ijms21145068
|
2 |
Mirza Ali Nazarnezhad, Mahdi Barazesh, Soudabeh Kavousipour, Shiva Mohammadi, Ebrahim Eftekhar, Sajad Jalili. The Computational Analysis of Single Nucleotide Associated with MicroRNA
Affecting Hepatitis B Infection. MicroRNA 2022; 11(2): 139 doi: 10.2174/2211536611666220509103724
|
3 |
Xiaolun Xu, Weiping Zhou, Xing Tian, Zhongjia Jiang, Xuanhe Fu, Jun Cao, Ye Sun, Biao Yang, Xueqian Li, Yanting Li, Chunmeng Zhang, Guangyan Liu. Peptide YY inhibits transcription and replication of hepatitis B virus by suppressing promoter/enhancer activity. Virus Genes 2023; 59(5): 678 doi: 10.1007/s11262-023-02017-8
|
4 |
Armando Calogero, Evangelista Sagnelli, Massimiliano Creta, Silvia Angeletti, Gaia Peluso, Paola Incollingo, Maria Candida, Gianluca Minieri, Nicola Carlomagno, Concetta Anna Dodaro, Massimo Ciccozzi, Caterina Sagnelli. Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/4674560
|
5 |
Javid Sadri Nahand, Sogol Jamshidi, Michael R. Hamblin, Maryam Mahjoubin-Tehran, Massoud Vosough, Marzieh Jamali, Alireza Khatami, Mohsen Moghoofei, Hossein Bannazadeh Baghi, Hamed Mirzaei. Circular RNAs: New Epigenetic Signatures in Viral Infections. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.01853
|
6 |
Yuan Li, Yanyan Wang, Zhaopu Song, Kai Lu, Wenwen Chen, Yuanyuan Ma, Hui Ding, Xiaofang Li, Xiuling Li, Suofeng Sun, Alamgeer Yuchi. Protein Acetylation Increased Risk of Fibrosis-Related Liver Cancer. Journal of Oncology 2023; 2023: 1 doi: 10.1155/2023/3624635
|
7 |
Shanfei Ge, Xiaoping Wu, Ying Xiong, Jianping Xie, Fei Liu, Wenfeng Zhang, Lixia Yang, Song Zhang, Lingling Lai, Jiansheng Huang, Ming Li, Yan-qing Yu. HMGB1 Inhibits HNF1A to Modulate Liver Fibrogenesis via p65/miR-146b Signaling. DNA and Cell Biology 2020; 39(9): 1711 doi: 10.1089/dna.2019.5330
|
8 |
Maria Guido, Alessandra Mangia, Neil D. Theise. MacSween's Pathology of the Liver. 2024; : 402 doi: 10.1016/B978-0-7020-8228-3.00006-5
|
9 |
Steven D. Hicks, Dongxiao Zhu, Rhea Sullivan, Nirupama Kannikeswaran, Kathleen Meert, Wei Chen, Srinivasan Suresh, Usha Sethuraman. Saliva microRNA Profile in Children with and without Severe SARS-CoV-2 Infection. International Journal of Molecular Sciences 2023; 24(9): 8175 doi: 10.3390/ijms24098175
|
10 |
Jing Xu, Jing Zhang, Fenglian Shan, Jie Wen, Yue Wang. SSTR5‑AS1 functions as a ceRNA to regulate CA2 by sponging miR‑15b‑5p for the development and prognosis of HBV‑related hepatocellular carcinoma. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10736
|
11 |
Tarek K. Motawi, Amira E. Mady, Samar Shaheen, Soha Z. Elshenawy, Roba M. Talaat, Sherine M. Rizk. Genetic variation in microRNA-100 (miR-100) rs1834306 T/C associated with Hepatitis B virus (HBV) infection: Correlation with expression level. Infection, Genetics and Evolution 2019; 73: 444 doi: 10.1016/j.meegid.2019.06.009
|
12 |
Caterina Sagnelli, Evangelista Sagnelli. Towards the worldwide eradication of hepatitis B virus infection: A combination of prophylactic and therapeutic factors. World Journal of Clinical Infectious Diseases 2019; 9(2): 11-22 doi: 10.5495/wjcid.v9.i2.11
|
13 |
Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli, Nicola Coppola. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention. World Journal of Gastroenterology 2019; 25(26): 3299-3312 doi: 10.3748/wjg.v25.i26.3299
|
14 |
Sepehr Yousefpouran, Shayan Mostafaei, Pegah Vahidi Manesh, Elmira Iranifar, Farah Bokharaei-Salim, Javid Sadri Nahand, Hamed Mirzaei, Mojtaba Taran, Farhad Babaei, Babak Sayad, Mohsen Moghoofei. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker. Microbial Pathogenesis 2020; 147: 104355 doi: 10.1016/j.micpath.2020.104355
|
15 |
Enas M. Hefzy, Noha A. Hassuna, Olfat G. Shaker, Mohamed Masoud, Tebyan A. Abelhameed, Tarek I. Ahmed, Nada F. Hemeda, Mohammed A. Abdelhakeem, Rania H. Mahmoud, Isabelle Chemin. miR-155 T/A (rs767649) and miR-146a A/G (rs57095329) single nucleotide polymorphisms as risk factors for chronic hepatitis B virus infection among Egyptian patients. PLOS ONE 2021; 16(8): e0256724 doi: 10.1371/journal.pone.0256724
|
16 |
Lulama Mthethwa, Raveen Parboosing, Nokukhanya Msomi. MicroRNA levels in patients with chronic hepatitis B virus and HIV coinfection in a high-prevalence setting; KwaZulu-Natal, South Africa. BMC Infectious Diseases 2024; 24(1) doi: 10.1186/s12879-024-09715-0
|
17 |
Fei Jing, Yan Geng, Xin-Yi Xu, Hong-Yu Xu, Jin-Song Shi, Zheng-Hong Xu. MicroRNA29a Reverts the Activated Hepatic Stellate Cells in the Regression of Hepatic Fibrosis through Regulation of ATPase H+ Transporting V1 Subunit C1. International Journal of Molecular Sciences 2019; 20(4): 796 doi: 10.3390/ijms20040796
|
18 |
Evangelista Sagnelli, Margherita Macera, Antonio Russo, Nicola Coppola, Caterina Sagnelli. Epidemiological and etiological variations in hepatocellular carcinoma. Infection 2020; 48(1): 7 doi: 10.1007/s15010-019-01345-y
|
19 |
Samar M. Shahen, Sohi Z. Elshenawy, Salwa E. Mohamed, Robe M. Talaat. Genetic polymorphisms in the miR-372 (rs12983273) and LncRNA HULC (rs7763881) genes and susceptibility to Hepatitis B virus (HBV) infection. Molecular Biology Reports 2021; 48(12): 7901 doi: 10.1007/s11033-021-06818-8
|
20 |
Jinghang Xu, Ping An, Cheryl A. Winkler, Yanyan Yu. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01271
|
21 |
Marina Manea, Ion Mărunțelu, Ileana Constantinescu. An In-Depth Approach to the Associations between MicroRNAs and Viral Load in Patients with Chronic Hepatitis B—A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 2024; 25(15): 8410 doi: 10.3390/ijms25158410
|
22 |
Chiara Siniscalchi, Armando Di Palo, Aniello Russo, Nicoletta Potenza. Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.678994
|